{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 8, "transaction_limit": 160, "filters": {"q": "", "ticker": "VYNE", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 8, "acquisition_count": 0, "disposal_count": 8, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 139507.4712, "disposal_value_label": "$139.5K", "net_value": -139507.4712, "net_value_label": "$-139.5K", "flow_tone": "negative", "largest_value_label": "$71.3K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 8, "value": "139507.4712", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$139.5K"}], "days": [{"transaction_date": "2026-06-30", "acquisitions": 0, "disposals": 4, "total": 4, "bar_width": 100.0}, {"transaction_date": "2026-07-23", "acquisitions": 0, "disposals": 4, "total": 4, "bar_width": 100.0}], "side_mix": {"acquisitions": 0, "disposals": 8, "acquisition_share": 0.0, "disposal_share": 100.0}}, "company_flows": [{"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-23", "acquisitions": 0, "disposals": 8, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 139507.4712, "disposed_value_label": "$139.5K", "net_value": -139507.4712, "net_value_label": "$-139.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}], "company_overview": [{"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-23", "filings": 8, "acquisitions": 0, "disposals": 8, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 139507.4712, "disposed_value_label": "$139.5K", "net_value": -139507.4712, "net_value_label": "$-139.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}], "transactions": [{"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "DOMZALSKI, DAVID", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 79391.0, "share_price": 0.8976, "transaction_value": 71261.3616, "fetched_at": "2026-07-30T10:58:50.941093+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HARSCH, MUTYA", "executive_title": "CHIEF LEGAL OFFICER AND GC", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 22516.0, "share_price": 0.8976, "transaction_value": 20210.3616, "fetched_at": "2026-07-30T10:58:50.938834+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "ZERONDA, TYLER", "executive_title": "CHIEF FINANCIAL OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 22516.0, "share_price": 0.8976, "transaction_value": 20210.3616, "fetched_at": "2026-07-30T10:58:50.942620+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STUART, IAIN", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15405.0, "share_price": 0.8976, "transaction_value": 13827.528, "fetched_at": "2026-07-30T10:58:50.932389+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "DOMZALSKI, DAVID", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 12214.0, "share_price": 0.6507, "transaction_value": 7947.6498, "fetched_at": "2026-07-21T11:14:49.747744+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HARSCH, MUTYA", "executive_title": "CHIEF LEGAL OFFICER AND GC", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3464.0, "share_price": 0.6507, "transaction_value": 2254.0248, "fetched_at": "2026-07-21T11:14:49.754713+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "ZERONDA, TYLER", "executive_title": "CHIEF FINANCIAL OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3464.0, "share_price": 0.6507, "transaction_value": 2254.0248, "fetched_at": "2026-07-21T11:14:49.750417+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "STUART, IAIN", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2370.0, "share_price": 0.6507, "transaction_value": 1542.159, "fetched_at": "2026-07-21T11:14:49.752607+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}